Trademark Overview
On Friday, March 14, 2025, a trademark application was filed for PANACCESS INNOVATIONS with the United States Patent and Trademark Office. The USPTO has given the PANACCESS INNOVATIONS trademark a serial number of 99084421. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, March 14, 2025. This trademark is owned by PanAccess Innovations Inc.. The PANACCESS INNOVATIONS trademark is filed in the Chemical Products, Computer & Software Products & Electrical & Scientific Products, and Computer & Software Services & Scientific Services categories with the following description:
AI-powered diagnostic platforms and biosensor technologies, namely, software for diagnostic data analysis, biosensor signal processing, and health monitoring; Software and Digital Solutions, namely, software for AI-driven diagnostics, laboratory automation, and data analysis; Software for data access, transfer and integration for diagnostic test interoperability, regulatory compliance, and secure data exchange; Digital platforms for remote diagnostics, decentralized testing, and clinical decision support
Biological and Biotechnological Products, namely enzymes, nucleic acids, and biochemical and molecular biology reagents and consumables for research, diagnostics, and industrial applications; Biomolecules and biomanufactured products, namely, biochemicals and biofuels for scientific, medical, veterinary, and agricultural use; Synthetic biology tools and genetically engineered materials, namely, engineered enzymes, microbial strains, and nucleic acid constructs for biotechnology, pharmaceutical development, and biomanufacturing; Diagnostics and Analytical Technologies, namely, in vitro diagnostic (IVD) kits for medical, food safety, veterinary, and agricultural use; Lateral flow assays, nucleic acid-based amplification tests, and point-of-care diagnostic tests; Biomanufacturing and Bio-Based Materials, namely, fermentation-based, cell-free, and bioprocessed products, comprising microbial-derived enzymes, bioactive metabolites, synthetic peptides, recombinant proteins, and nucleic acid-b...
Software and Digital Solutions, Software as a services (SaaS) featuring software for AI-driven diagnostics, laboratory automation, and data analysis; Cloud-based Platform as a Services (PaaS) featuring bioinformatics platforms for genomic analysis, biomarker identification, and diagnostic data processing; Non-downloadable digital platforms for remote diagnostics, decentralized testing, and clinical decision support; Non-downloadable AI-powered diagnostic platforms and biosensor technologies, namely, software for diagnostic data analysis, biosensor signal processing, and health monitoring